Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription 11.07.2022 12 Ann Surg Oncol 4 Anticancer Res 2 BMC Cancer 1 BMC Gastroenterol 1 Dig Dis 3 Eur J Cancer 1 Eur J Surg Oncol 3 Gastroenterology 1 Gut 2 Int J Colorectal Dis 1 J Surg Oncol 3 N Engl J Med 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. SAMPURNO S, Chittleborough T, Dean M, Flood M, et al
   Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery: A Randomized Controlled Trial.
   Ann Surg Oncol. 2022 Jul 6. pii: 10.1245/s10434-022-12057.
   PubMed         Abstract available
   
   
2. MATSUGUMA H, Mun M, Sano A, Yoshino I, et al
   ASO Visual Abstract: Time to Incurable Recurrence for Patients Who Receive Pulmonary Metastasectomy for Colorectal Cancer.
   Ann Surg Oncol. 2022 Jul 4. pii: 10.1245/s10434-022-12073.
   PubMed        
   
   
3. PEDRAZZANI C, Turri G, Marrelli D, Kim HJ, et al
   Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort.
   Ann Surg Oncol. 2022 Jul 5. pii: 10.1245/s10434-022-12097.
   PubMed         Abstract available
   
   
4. LUO W, Lu T, Xiao Y
   ASO Author Reflections: A New "Superior Mesenteric Artery-First" Approach for Complete Mesocolic Excision with Central Vascular Ligation in Laparoscopic Right Hemicolectomy.
   Ann Surg Oncol. 2022;29:5074-5075.
   PubMed        
   
   
5. COSTANTINI B, Vargiu V, Santullo F, Rosati A, et al
   Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience.
   Ann Surg Oncol. 2022;29:4791-4802.
   PubMed         Abstract available
   
   
6. SAID I, Ubink I, Ewalds RSG, Arkesteijn JGT, et al
   In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival.
   Ann Surg Oncol. 2022;29:5256-5262.
   PubMed         Abstract available
   
   
7. MASON MC, Krasnodebski M, Hester CA, Kothari AN, et al
   Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection.
   Ann Surg Oncol. 2022;29:5156-5164.
   PubMed         Abstract available
   
   
8. TAIBI A, Hubner M, Eveno C, Dumont F, et al
   ASO Author Reflections: Is There Still a Role for Intraperitoneal Oxaliplatin for Colorectal Peritoneal Metastases?
   Ann Surg Oncol. 2022;29:5252-5253.
   PubMed        
   
   
9. AIBUEDEFE B, Hamilton KS, Yong V, Kling SM, et al
   It's Not About the Money: Continued Treatment and Survival Outcome Disparities in Minority Rectal Cancer Patients After Controlling for Socioeconomic Factors.
   Ann Surg Oncol. 2022;29:5056-5062.
   PubMed         Abstract available
   
   
10. TAIBI A, Sgarbura O, Hubner M, Bardet SM, et al
    Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study.
    Ann Surg Oncol. 2022;29:5243-5251.
    PubMed         Abstract available
    
    
11. HAMILTON KS, Aibuedefe B, Yong V, Kling SM, et al
    ASO Author Reflections: Inequities in Rectal Cancer Treatment and Survival.
    Ann Surg Oncol. 2022;29:5063-5064.
    PubMed        
    
    
12. CARBONI F, Valle M
    Letter to Editor of Annals of Surgical Oncology Concerning "Early Diagnosis of Anastomotic Leakage after Gastric Cancer Surgery via Analysis of Inflammatory Factors in Abdominal Drainage".
    Ann Surg Oncol. 2022;29:5107-5108.
    PubMed        
    
    

    
    Anticancer Res

13. HIRAIDE T, Morita Y, Horikawa M, Sugiyama E, et al
    Saturated Fatty Acids in Cell Membrane Lipids Induce Resistance to 5-Fluorouracil in Colorectal Cancer Cells.
    Anticancer Res. 2022;42:3313-3324.
    PubMed         Abstract available
    
    
14. MINAMI S, Miyoshi N, Fujino S, Kato S, et al
    The Geriatric Nutritional Risk Index as a Prognosis Predictor in Patients With Rectal Cancer Receiving Neoadjuvant Chemotherapy.
    Anticancer Res. 2022;42:3759-3766.
    PubMed         Abstract available
    
    
15. ESKELINEN M, Meklin J, Guimaraes DP, Selander T, et al
    Site-specific Performance of ColonView (CV) Fecal Immunochemical Test (FIT) With Differences Between Proximal and Distal Colorectal Adenoma.
    Anticancer Res. 2022;42:3557-3567.
    PubMed         Abstract available
    
    
16. KATAOKA S, Arita T, Konishi H, Yamamoto Y, et al
    The Role of Inflammation-associated microRNA-4257 as a Promoter of Malignancy in Colorectal Cancer.
    Anticancer Res. 2022;42:3349-3360.
    PubMed         Abstract available
    
    

    
    BMC Cancer

17. SONG Z, Liu K, Zhang T, Wang B, et al
    Oncologic outcomes of single-incision laparoscopic surgery versus conventional laparoscopic surgery for colorectal cancer (CSILS): study protocol for a multicentre, prospective, open-label, noninferiority, randomized controlled trial.
    BMC Cancer. 2022;22:743.
    PubMed         Abstract available
    
    
18. ZAINAL ABIDIN MN, Omar MS, Islahudin F, Mohamed Shah N, et al
    The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer.
    BMC Cancer. 2022;22:731.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

19. CAO G, Wang X, Chen H, Gao S, et al
    Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study.
    BMC Gastroenterol. 2022;22:328.
    PubMed         Abstract available
    
    

    
    Dig Dis

20. MONTALE A, Buttitta F, Pierantoni C, Ferrari C, et al
    Chromoendoscopy Is Not Superior to White Light Endoscopy in Improving Adenoma Detection in Lynch Syndrome Cohort Undergoing Surveillance with High-Resolution Colonoscopy: A Real-World Evidence Study.
    Dig Dis. 2022;40:517-525.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

21. MAZZOLI G, Cohen R, Lonardi S, Corti F, et al
    Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer.
    Eur J Cancer. 2022;172:171-181.
    PubMed         Abstract available
    
    
22. DERANGERE V, Lecuelle J, Lepage C, Aoulad-Ben Salem O, et al
    Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.
    Eur J Cancer. 2022;172:221-230.
    PubMed         Abstract available
    
    
23. SIMILLIS C, Taylor B, Ahmad A, Lal N, et al
    A systematic review and meta-analysis assessing the impact of body mass index on long-term survival outcomes after surgery for colorectal cancer.
    Eur J Cancer. 2022;172:237-251.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

24. BHIMANI N, Wong GY, Molloy C, Dieng M, et al
    Cost of colorectal cancer by treatment type from different health economic perspectives: A systematic review.
    Eur J Surg Oncol. 2022 Jun 23. pii: S0748-7983(22)00528.
    PubMed         Abstract available
    
    

    
    Gastroenterology

25. WOODFIELD G, Belluomo I, Laponogov I, Veselkov K, et al
    Diagnostic performance of a non-invasive breath test for colorectal cancer: COBRA1 study.
    Gastroenterology. 2022 Jul 5. pii: S0016-5085(22)00747.
    PubMed        
    
    
26. GAO R, Wu C, Zhu Y, Kong C, et al
    Integrated analysis of colorectal cancer reveals cross-cohort gut microbial signatures and associated serum metabolites.
    Gastroenterology. 2022 Jul 1. pii: S0016-5085(22)00731.
    PubMed         Abstract available
    
    
27. JUNCA H, Pieper DH
    Hundreds of Novel DNA Viruses From a Single Healthy Patient: Biomarker Potential for Colorectal Cancer.
    Gastroenterology. 2022 Jun 30. pii: S0016-5085(22)00737.
    PubMed        
    
    

    
    Gut

28. BONNEREAU J, Courau T, Asesio N, Salfati D, et al
    Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition.
    Gut. 2022 Jul 8. pii: gutjnl-2021-326553. doi: 10.1136/gutjnl-2021-326553.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

29. SHI J, Li Y, Song W, Wang M, et al
    Risk of colon cancer-related death in people who had cancer in the past.
    Int J Colorectal Dis. 2022 Jul 7. pii: 10.1007/s00384-022-04202.
    PubMed         Abstract available
    
    
30. MASSA I, Ghignone F, Ugolini G, Ercolani G, et al
    Emilia-Romagna Surgical Colorectal Cancer Audit (ESCA): a value-based healthcare retro-prospective study to measure and improve the quality of surgical care in colorectal cancer.
    Int J Colorectal Dis. 2022;37:1727-1738.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

31. DUMONT F, Loaec C, Wernert R, Maurel B, et al
    Surgery of resectable local recurrence following colorectal cancer: Compartmental surgery improves local control.
    J Surg Oncol. 2022 Jul 2. doi: 10.1002/jso.26990.
    PubMed         Abstract available
    
    

    
    N Engl J Med

32. SINICROPE FA
    The Increasing Incidence of Early-Onset Colorectal Cancer. Reply.
    N Engl J Med. 2022;387:93-94.
    PubMed        
    
    
33. GOLDSTEIN MR, Mascitelli L
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:93.
    PubMed        
    
    
34. WOLOSHIN S, Kramer BS
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:91-93.
    PubMed        
    
    

    
    Oncogene

35. YOU A, Tian W, Yuan H, Gu L, et al
    TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern.
    Oncogene. 2022 Jul 7. pii: 10.1038/s41388-022-02402.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: